Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Ugandan national guidelines recommend initiation of combination antiretroviral therapy (cART) at CD4+ T cell (CD4) count below 350 cell/μl, but the implementation of this is limited due to availability of medication. However, cART initiation at higher CD4 count increases survival, albeit at higher lifetime treatment cost. This analysis evaluates th...
Alternative Titles
Full title
Cost-effectiveness of early initiation of first-line combination antiretroviral therapy in Uganda
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_1a84303ba6ab43428f66a965589a4e14
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1a84303ba6ab43428f66a965589a4e14
Other Identifiers
ISSN
1471-2458
E-ISSN
1471-2458
DOI
10.1186/1471-2458-12-736
